Table 2 Association between serum OPN levels and clinicopathological characteristics in SCLC patients
From: Prognostic significance of serum osteopontin levels in small cell lung cancer
Characteristics | Number | OPN level (ng/ml) | P |
|---|---|---|---|
Age, yr | 0.954 | ||
≥ 60 | 54 | 73.78 ± 16.55 | |
< 60 | 42 | 73.43 ± 17.90 | |
Gender | 0.317 | ||
Male | 66 | 75.38 ± 16.44 | |
Female | 30 | 68.38 ± 18.19 | |
Smoking history | 0.077 | ||
Ever smoker | 58 | 68.32 ± 20.11 | |
Never smoker | 38 | 78.94 ± 11.13 | |
Performance status | 0.174 | ||
0–1 | 56 | 70.02 ± 17.39 | |
2–3 | 40 | 78.27 ± 15.55 | |
Disease stage | 0.012 | ||
Limited | 28 | 66.32 ± 19.64 | |
Extended | 58 | 80.94 ± 9.41 | |
Tumor size (cm) | 0.034 | ||
≥ 3 | 76 | 77.96 ± 14.31 | |
< 3 | 20 | 60.63 ± 18.18 | |
Lymph node metastasis | 0.037 | ||
N0 | 26 | 64.08 ± 21.85 | |
N1–3 | 70 | 79.40 ± 9.72 | |
Responses | 0.485 | ||
CR + PR | 78 | 71.15 ± 18.33 | |
SD + PD | 18 | 78.01 ± 13.74 |